Dss, Inc. DSS
We take great care to ensure that the data presented and summarized in this overview for DSS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in DSS
Top Purchases
Top Sells
About DSS
DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, it focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engaged in?nonbanking activities related to banking, including loan syndication services, mortgage banking, trust and escrow services, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services, as well as operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers; and focuses on developing healthy living communities. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as operates as a digital assets broker dealer; and offers solar farms, solar battery banks, and residential energy creation and storage services. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.
Insider Transactions at DSS
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 29
2023
|
William Wai Leung Wu Director |
SELL
Open market or private sale
|
Direct |
1,020
-100.0%
|
$0
$0.13 P/Share
|
Dec 29
2023
|
William Wai Leung Wu Director |
SELL
Open market or private sale
|
Indirect |
150,000
-100.0%
|
$0
$0.13 P/Share
|
Dec 28
2023
|
Heng Fai Ambrose Chan Director |
BUY
Open market or private purchase
|
Direct |
672,173
+3.32%
|
$0
$0.15 P/Share
|
Apr 10
2023
|
Frank D Heuszel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,247,078
+48.72%
|
$0
$0.22 P/Share
|
Dec 13
2022
|
Heng Fai Ambrose Chan Director |
BUY
Open market or private purchase
|
Direct |
334,921
+1.74%
|
$0
$0.23 P/Share
|
Dec 09
2022
|
Heng Fai Ambrose Chan Director |
BUY
Open market or private purchase
|
Direct |
51,385
+0.28%
|
$0
$0.19 P/Share
|
Jul 12
2022
|
Heng Fai Ambrose Chan Director |
BUY
Other acquisition or disposition
|
Indirect |
21,366,177
+20.79%
|
-
|
Jul 07
2022
|
Heng Fai Ambrose Chan Director |
BUY
Open market or private purchase
|
Indirect |
17,570,948
+22.64%
|
-
|
Jun 17
2022
|
William Wai Leung Wu Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+3.2%
|
$0
$0.38 P/Share
|
Jun 16
2022
|
William Wai Leung Wu Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+3.31%
|
$0
$0.38 P/Share
|
Jun 10
2022
|
William Wai Leung Wu Director |
BUY
Open market or private purchase
|
Indirect |
27,000
+16.17%
|
$0
$0.41 P/Share
|
Jun 09
2022
|
William Wai Leung Wu Director |
BUY
Open market or private purchase
|
Indirect |
72,600
+39.12%
|
$0
$0.42 P/Share
|
Jun 08
2022
|
William Wai Leung Wu Director |
BUY
Open market or private purchase
|
Indirect |
23,651
+36.93%
|
$0
$0.41 P/Share
|
Jun 07
2022
|
William Wai Leung Wu Director |
BUY
Open market or private purchase
|
Indirect |
16,749
+50.0%
|
$0
$0.39 P/Share
|
May 25
2022
|
Heng Fai Ambrose Chan Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,389,995
+47.55%
|
-
|
May 04
2022
|
Frank D Heuszel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,205
+49.03%
|
$0
$0.45 P/Share
|
Apr 01
2022
|
Heng Fai Ambrose Chan Director |
BUY
Grant, award, or other acquisition
|
Direct |
894,084
+36.09%
|
-
|
Mar 09
2022
|
Heng Fai Ambrose Chan Director |
BUY
Open market or private purchase
|
Indirect |
3,986,877
+13.22%
|
$0
$0.38 P/Share
|
Sep 08
2021
|
Heng Fai Ambrose Chan Director |
BUY
Open market or private purchase
|
Indirect |
12,155,591
+35.39%
|
$12,155,591
$1.23 P/Share
|
Jun 21
2021
|
Heng Fai Ambrose Chan Director |
BUY
Conversion of derivative security
|
Indirect |
1,120,170
+10.04%
|
-
|
Last 12 Months Summary
Open market or private purchase | 672K shares |
---|
Open market or private sale | 151K shares |
---|